X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

September 02, 2020

SARS-CoV-2 Vaccines – Alternative Vial Components

The need to provide vaccines for the SARS-CoV-2 pandemic has presented the pharmaceutical industry with unprecedented challenges. Among them are accelerated timelines for development/approval and unanticipated volumes for manufacture/delivery. Ordinarily for a new drug product, there is ample time for selecting the primary package system and establishing component availability.
Whitney Winters

Whitney Winters

Sr. Director, Strategic Marketing, Containment Systems

Previous Posts
P3 Vials

April 17, 2020

Light Sensitive Drug Products Need Protection

Nico Brandes

Nico Brandes

Director, Product Management, Vial Containment & Prefillable Systems

Vials Syringes and Cartridges

September 16, 2019

How They Are Made - Polymer-Based Containers for Parenteral Drugs

Katie Espenshade

Katie Espenshade

Sr Technical Account Specialist, TCS, NA

Daikyo Crystal Zenith Insert Needle Syringes

March 21, 2019

When to Use a Cyclic Olefin Polymer Prefilled Syringe

Nico Brandes

Nico Brandes

Director, Product Management, Vial Containment & PFS

Load more